HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TBX6
T-box transcription factor 6
Chromosome 16 Β· 16p11.2
NCBI Gene: 6911Ensembl: ENSG00000149922.13HGNC: HGNC:11605UniProt: O95947
40PubMed Papers
21Diseases
0Drugs
23Pathogenic Variants
FUNCTIONAL ROLE
Transcription Factor
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
sequence-specific double-stranded DNA bindingDNA-binding transcription activator activityprotein bindingDNA bindingspondylocostal dysostosis 5scoliosisautosomal dominant spondylocostal dysostosisgenetic disorder
✦AI Summary

TBX6 is a T-box transcription factor that functions as a master regulator of paraxial mesoderm specification during embryonic development 1. It plays a critical role in determining cell fate decisions between neural and mesodermal lineages by suppressing neural development through downregulation of SOX2 enhancers 2. During somitogenesis, TBX6 acts as a key segmentation clock component regulating vertebral formation 3. Genetically, TBX6 operates through compound inheritance mechanisms in congenital vertebral malformations (CVMs). Heterozygous null mutations and common hypomorphic alleles together account for approximately 11% of congenital scoliosis cases 4. Conversely, increased TBX6 dosage from 16p11.2 duplications also causes CVMs, particularly affecting cervical vertebrae, with 60% of mice with elevated Tbx6 expression manifesting spinal defects 5. These dosage-sensitive effects highlight the importance of precise TBX6 expression levels. Beyond skeletal development, TBX6 participates in myogenic differentiation and cardiac pathophysiology. During skeletal muscle organoid development, TBX6-positive paraxial mesodermal progenitors constitute the primary myogenic lineage 6. In cardiac tissue, the Dot1L-mediated histone modification axis promotes Tbx6 expression, which drives stress-induced cardiac hypertrophy 7. TBX6 variants have also been associated with Mayer-Rokitansky-KΓΌster-Hauser syndrome through 16p11.2 deletions 8.

Sources cited
1
TBX6 plays an important role in somitogenesis and congenital vertebral malformation pathogenesis
PMID: 27437870
2
TBX6 deletions at 16p11.2 are associated with MRKH syndrome
PMID: 38699388
3
TBX6 null mutations and hypomorphic alleles cause ~11% of congenital scoliosis through compound inheritance
PMID: 25564734
4
TBX6 transcription factor is essential for presomitic mesoderm development and somite formation in human embryos
PMID: 39164488
5
TBX6-positive cells represent paraxial mesodermal progenitors in skeletal muscle organoid development
PMID: 40810394
6
TBX6 is a T-box transcription factor important for paraxial mesoderm specification
PMID: 9933572
7
Increased TBX6 dosage from 16p11.2 duplication causes congenital vertebral malformations in humans and mice
PMID: 31888956
8
Dot1L-catalyzed H3K79 dimethylation promotes Tbx6 expression, driving stress-induced cardiac hypertrophy
PMID: 40583756
Disease Associationsβ“˜21
spondylocostal dysostosis 5Open Targets
0.69Moderate
scoliosisOpen Targets
0.52Moderate
autosomal dominant spondylocostal dysostosisOpen Targets
0.51Moderate
genetic disorderOpen Targets
0.45Moderate
autosomal recessive spondylocostal dysostosisOpen Targets
0.39Weak
multiple sclerosisOpen Targets
0.27Weak
asthmaOpen Targets
0.21Weak
polyp of colonOpen Targets
0.21Weak
Neurodevelopmental abnormalityOpen Targets
0.15Weak
type 2 diabetes mellitusOpen Targets
0.14Weak
Posterior fusion of lumbosacral vertebrae - blepharoptosisOpen Targets
0.08Suggestive
posterior fusion of lumbosacral vertebrae-blepharoptosis syndromeOpen Targets
0.08Suggestive
spondylocostal dysostosis 2, autosomal recessiveOpen Targets
0.07Suggestive
cervical spondylosisOpen Targets
0.07Suggestive
Klippel-Feil syndrome 3, autosomal dominantOpen Targets
0.06Suggestive
Familial Scheuermann diseaseOpen Targets
0.06Suggestive
Scheuermann diseaseOpen Targets
0.06Suggestive
brachyolmia, Maroteaux typeOpen Targets
0.06Suggestive
mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritisOpen Targets
0.06Suggestive
neural tube defects, folate-sensitiveOpen Targets
0.06Suggestive
Spondylocostal dysostosis 5UniProt
Pathogenic Variants23
NM_004608.4(TBX6):c.834dup (p.Lys279Ter)Likely pathogenic
TBX6-related disorder|Spondylocostal dysostosis 5
β˜…β˜…β˜†β˜†2025β†’ Residue 279
NM_004608.4(TBX6):c.370del (p.Cys124fs)Likely pathogenic
TBX6-related disorder|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 124
NM_004608.4(TBX6):c.1018_1019del (p.Leu340fs)Pathogenic
Spondylocostal dysostosis 5|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 340
NM_004608.4(TBX6):c.989_990dup (p.Gly331fs)Likely pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2024β†’ Residue 331
NM_004608.4(TBX6):c.990del (p.Glu332fs)Pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2024β†’ Residue 332
NM_004608.4(TBX6):c.117del (p.Glu40fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 40
NM_004608.4(TBX6):c.1112dup (p.Glu372fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 372
NM_004608.4(TBX6):c.699G>A (p.Trp233Ter)Pathogenic
Inborn genetic diseases
β˜…β˜†β˜†β˜†2022β†’ Residue 233
NM_004608.4(TBX6):c.1143dup (p.Tyr382fs)Pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2020β†’ Residue 382
NM_004608.4(TBX6):c.914-2A>CLikely pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2020
NM_004608.4(TBX6):c.1148C>A (p.Ser383Ter)Pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2020β†’ Residue 383
NM_004608.4(TBX6):c.424G>T (p.Asp142Tyr)Likely pathogenic
Scoliosis
β˜…β˜†β˜†β˜†2019β†’ Residue 142
NM_004608.4(TBX6):c.473_475dup (p.Trp158_Glu159insGly)Pathogenic
Scoliosis
β˜…β˜†β˜†β˜†2019β†’ Residue 158
NM_004608.4(TBX6):c.418C>T (p.Leu140Phe)Pathogenic
Scoliosis
β˜…β˜†β˜†β˜†2019β†’ Residue 140
NM_004608.4(TBX6):c.704dup (p.Met236fs)Pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2015β†’ Residue 236
NM_004608.4(TBX6):c.266dup (p.Val91fs)Pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2015β†’ Residue 91
NM_004608.4(TBX6):c.1250dup (p.Leu419fs)Pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2015β†’ Residue 419
NM_004608.4(TBX6):c.1169dup (p.His391fs)Pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2015β†’ Residue 391
NM_004608.4(TBX6):c.1179_1180del (p.Gly395fs)Pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†2015β†’ Residue 395
NM_004608.4(TBX6):c.1309T>C (p.Ter437Arg)Likely pathogenic
Spondylocostal dysostosis 5
β˜…β˜†β˜†β˜†β†’ Residue 437
View on ClinVar β†—
Related Genes
FGFR1Protein interaction100%MSGN1Protein interaction94%MESP2Protein interaction93%DLL1Protein interaction90%FGF8Protein interaction87%WNT3AProtein interaction84%
Tissue Expression6 tissues
Liver
100%
Ovary
99%
Lung
71%
Brain
42%
Heart
35%
Bone Marrow
28%
Gene Interaction Network
Click a node to explore
TBX6FGFR1MSGN1MESP2DLL1FGF8WNT3A
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt O95947
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.94LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.69 [0.51–0.94]
RankingsWhere TBX6 stands among ~20K protein-coding genes
  • #10,251of 20,598
    Most Researched40
  • #2,071of 5,498
    Most Pathogenic Variants23
  • #8,691of 17,882
    Most Constrained (LOEUF)0.94
Genes detectedTBX6
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Progress and perspective of TBX6 gene in congenital vertebral malformations.
PMID: 27437870
Oncotarget Β· 2016
1.00
2
Genetics of Mayer-Rokitansky-KΓΌster-Hauser (MRKH) syndrome: advancements and implications.
PMID: 38699388
Front Endocrinol (Lausanne) Β· 2024
0.90
3
TBX6 null variants and a common hypomorphic allele in congenital scoliosis.
PMID: 25564734
N Engl J Med Β· 2015
0.80
4
Retinoic acid induces human gastruloids with posterior embryo-like structures.
PMID: 39164488
Nat Cell Biol Β· 2024
0.70
5
Human Pluripotent Stem Cell-Derived Skeletal Muscle Organoid Model of Aging-Induced Sarcopenia.
PMID: 40810394
J Cachexia Sarcopenia Muscle Β· 2025
0.60